-
Something wrong with this record ?
Occupational exposure to endocrine disruptors and lymphoma risk in a multi-centric European study
L. Costas, C. Infante-Rivard, JP. Zock, M. Van Tongeren, P. Boffetta, A. Cusson, C. Robles, D. Casabonne, Y. Benavente, N. Becker, P. Brennan, L. Foretova, M. Maynadié, A. Staines, A. Nieters, P. Cocco, S. de Sanjosé,
Language English Country England, Great Britain
Document type Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't
NLK
Free Medical Journals
from 1947 to 1 year ago
Freely Accessible Journals
from 1947 to 1 year ago
PubMed Central
from 1947 to 1 year ago
Europe PubMed Central
from 1947 to 1 year ago
ProQuest Central
from 2000-01-01 to 2017-12-31
Open Access Digital Library
from 1947-01-01
Open Access Digital Library
from 1999-01-01
Medline Complete (EBSCOhost)
from 1999-01-01 to 2015-11-17
Nursing & Allied Health Database (ProQuest)
from 2000-01-01 to 2017-12-31
Health & Medicine (ProQuest)
from 2000-01-01 to 2017-12-31
Public Health Database (ProQuest)
from 2000-01-01 to 2017-12-31
PubMed
25742473
DOI
10.1038/bjc.2015.83
Knihovny.cz E-resources
- MeSH
- Endocrine Disruptors poisoning MeSH
- Incidence MeSH
- Humans MeSH
- Lymphoma chemically induced epidemiology MeSH
- Occupational Diseases chemically induced epidemiology MeSH
- Occupational Exposure adverse effects statistics & numerical data MeSH
- Risk Factors MeSH
- Sex Factors MeSH
- Case-Control Studies MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Multicenter Study MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Europe MeSH
BACKGROUND: Incidence rates of lymphoma are usually higher in men than in women, and oestrogens may protect against lymphoma. METHODS: We evaluated occupational exposure to endocrine disrupting chemicals (EDCs) among 2457 controls and 2178 incident lymphoma cases and subtypes from the European Epilymph study. RESULTS: Over 30 years of exposure to EDCs compared to no exposure was associated with a 24% increased risk of mature B-cell neoplasms (P-trend=0.02). Associations were observed among men, but not women. CONCLUSIONS: Prolonged occupational exposure to endocrine disruptors seems to be moderately associated with some lymphoma subtypes.
] CIBER Epidemiologia y Salud Pública 08003 Barcelona Spain
Centre de Recherche CHU Sainte Justine Montréal QC Canada H3T 1C4
Centre for Human Exposure Science Institute of Occupational Medicine EH14 4AP Edinburgh UK
IARC International Agency for Research on Cancer 69372 Lyon France
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15022798
- 003
- CZ-PrNML
- 005
- 20150729121301.0
- 007
- ta
- 008
- 150709s2015 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/bjc.2015.83 $2 doi
- 035 __
- $a (PubMed)25742473
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Costas, L $u 1] Unit of Infections and Cancer, Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, 08908 Barcelona, Spain [2] Department of Medicine, University of Barcelona, 08036 Barcelona, Spain [3] CIBER Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain.
- 245 10
- $a Occupational exposure to endocrine disruptors and lymphoma risk in a multi-centric European study / $c L. Costas, C. Infante-Rivard, JP. Zock, M. Van Tongeren, P. Boffetta, A. Cusson, C. Robles, D. Casabonne, Y. Benavente, N. Becker, P. Brennan, L. Foretova, M. Maynadié, A. Staines, A. Nieters, P. Cocco, S. de Sanjosé,
- 520 9_
- $a BACKGROUND: Incidence rates of lymphoma are usually higher in men than in women, and oestrogens may protect against lymphoma. METHODS: We evaluated occupational exposure to endocrine disrupting chemicals (EDCs) among 2457 controls and 2178 incident lymphoma cases and subtypes from the European Epilymph study. RESULTS: Over 30 years of exposure to EDCs compared to no exposure was associated with a 24% increased risk of mature B-cell neoplasms (P-trend=0.02). Associations were observed among men, but not women. CONCLUSIONS: Prolonged occupational exposure to endocrine disruptors seems to be moderately associated with some lymphoma subtypes.
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a endokrinní disruptory $x otrava $7 D052244
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a incidence $7 D015994
- 650 _2
- $a lymfom $x chemicky indukované $x epidemiologie $7 D008223
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a nemoci z povolání $x chemicky indukované $x epidemiologie $7 D009784
- 650 _2
- $a pracovní expozice $x škodlivé účinky $x statistika a číselné údaje $7 D016273
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a sexuální faktory $7 D012737
- 651 _2
- $a Evropa $x epidemiologie $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a multicentrická studie $7 D016448
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Infante-Rivard, C $u Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University, Montréal, QC, Canada H3A 1A2.
- 700 1_
- $a Zock, J-P $u 1] CIBER Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain [2] Netherlands Institute for Health Services Research (NIVEL), 3500 Utrecht, The Netherlands [3] Centre for Research in Environmental Epidemiology (CREAL), 08003 Barcelona, Spain [4] Universitat Pompeu Fabra (UPF), 08003 Barcelona, Spain.
- 700 1_
- $a Van Tongeren, M $u Centre for Human Exposure Science (CHES), Institute of Occupational Medicine, EH14 4AP Edinburgh, UK.
- 700 1_
- $a Boffetta, P $u Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, 10029 NY, USA.
- 700 1_
- $a Cusson, A $u Centre de Recherche, CHU Sainte-Justine, Montréal, QC, Canada H3T 1C4.
- 700 1_
- $a Robles, C $u Unit of Infections and Cancer, Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, 08908 Barcelona, Spain.
- 700 1_
- $a Casabonne, D $u 1] Unit of Infections and Cancer, Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, 08908 Barcelona, Spain [2] CIBER Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain.
- 700 1_
- $a Benavente, Y $u 1] Unit of Infections and Cancer, Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, 08908 Barcelona, Spain [2] CIBER Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain.
- 700 1_
- $a Becker, N $u Division of Cancer Epidemiology, German Cancer Research Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
- 700 1_
- $a Brennan, P $u IARC, International Agency for Research on Cancer, 69372 Lyon, France.
- 700 1_
- $a Foretova, L $u Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute and MF MU, 65653 Brno, Czech Republic.
- 700 1_
- $a Maynadié, M $u Biological Hematology Unit, CRB Ferdinand Cabanne, Universitary Hospital of Dijon and EA4184, University of Burgundy, EA 4184 Dijon, France.
- 700 1_
- $a Staines, A $u Public Health University College, Dublin, Ireland.
- 700 1_
- $a Nieters, A $u Centre of Chronic Immunodeficiency, Molecular Epidemiology, University Medical Center Freiburg, 79106 Freiburg, Germany.
- 700 1_
- $a Cocco, P $u Department of Public Health, Clinical and Molecular Medicine, Occupational Health Section, University of Cagliari, 09124 Cagliari, Italy.
- 700 1_
- $a de Sanjosé, S $u 1] Unit of Infections and Cancer, Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, 08908 Barcelona, Spain [2] Department of Medicine, University of Barcelona, 08036 Barcelona, Spain [3] CIBER Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain.
- 773 0_
- $w MED00009369 $t British journal of cancer $x 1532-1827 $g Roč. 112, č. 7 (2015), s. 1251-6
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25742473 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150709 $b ABA008
- 991 __
- $a 20150729121347 $b ABA008
- 999 __
- $a ok $b bmc $g 1083137 $s 905791
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 112 $c 7 $d 1251-6 $i 1532-1827 $m British journal of cancer $n Br J Cancer $x MED00009369
- LZP __
- $a Pubmed-20150709
